Body warns BBVA that "the Government has the last word" in the takeover bid for Sabadell
Finding yourself face to face with a man or a bear? The debate that shakes up social networks
Sabadell rejects the merger with BBVA and will fight to remain alone
In Germany, the far left wants to cap the price of “doner kebabs”
The presence of blood in the urine, a warning sign of bladder cancer
A baby whose mother smoked during pregnancy will age more quickly
The euro zone economy grows in April at its best pace in almost a year but inflationary pressure increases
Children born thanks to PMA do not have more cancers than others
Argentina: the street once again raises its voice against President Javier Milei
Spain: BBVA bank announces a hostile takeover bid for its competitor Sabadell
New black series for Boeing: eleven injured after a plane went off the runway in Dakar
“The prices are astronomical”: to enjoy the Olympics with family, Sabrina spent... 8,000 euros
Berry affair: Jeane Manson victim of a heart problem after a court hearing
Venice Film Festival: Isabelle Huppert will chair the jury of the 81st festival
Louvre: Delacroix’s “Liberty Leading the People” target of the Riposte Alimentaire collective
The Coubertin Spirit, Eternal Memory, Planet of the Apes... Films to watch this week
Omoda 7, another Chinese car that could be manufactured in Spain
BYD chooses CA Auto Bank as financial partner in Spain
Tesla and Baidu sign key agreement to boost development of autonomous driving
Skoda Kodiaq 2024: a 'beast' plug-in hybrid SUV
The home mortgage firm rises 3.8% in February and the average interest moderates to 3.33%
This is how housing prices have changed in Spain in the last decade
The home mortgage firm drops 10% in January and interest soars to 3.46%
The jewel of the Rocío de Nagüeles urbanization: a dream villa in Marbella
Institutions: senators want to restore the accumulation of mandates and put an end to the automatic presence of ex-presidents on the Constitutional Council
Europeans: David Lisnard expresses his “essential and vital” support for François-Xavier Bellamy
Facing Jordan Bardella, the popularity match turns to Gabriel Attal’s advantage
Europeans: a senior official on the National Rally list
These French cities that will boycott the World Cup in Qatar
Football: mysterious serial attacks on footballers in Malaysia
Paris 2024 Olympic Games: “a shame”, “level 0 of music”… The choice of JUL deeply regretted on social networks
Real Madrid-Bayern Munich: “I feel bad”, Manuel Neuer a fallen hero
Mercato: Nacho should leave Real Madrid at the end of the season
The drug Jemperli (trade name of dostarlimab), already available in France since October as part of a so-called early access procedure, has received the European green light to be marketed, the British pharmaceutical laboratory GlaxoSmithKline announced in a press release ( GSK), which markets it.
This monoclonal antibody is intended, in combination with carboplatin and paclitaxel (chemotherapy), for women suffering from newly diagnosed or recurrent advanced endometrial cancer. The endometrium is the inner lining of the uterus, which is shed during menstruation. This cancer is the 4th most common in France with more than 8,000 cases per year. It generally affects women after menopause and the prognosis is relatively good compared to other female cancers (cervical, ovarian, etc.), but it remains the cause of many deaths.
This decision was made on the basis of a study which demonstrated a positive effect of the treatment on the “progression-free survival” of cancer, that is to say the duration during which a patient does not experience a worsening of his or her disease. disease, but also on “overall survival”, indicates GSK.
